Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

UCB INC

  • FDA Approval
  • Oct. 18, 2023, 11:39 UTC
  • 28
  • 0 comments

FDA approve LACOSAMIDE

Comment Full text

PFIZER INC

  • FDA Approval
  • Oct. 18, 2023, 11:39 UTC
  • 28
  • 0 comments

FDA approve RITUXIMAB-PVVR

Comment Full text

CEROVENE INC

  • FDA Approval
  • Oct. 18, 2023, 11:39 UTC
  • 30
  • 0 comments

FDA approve AMPHETAMINE SULFATE

Comment Full text

GLENMARK PHARMS LTD

  • FDA Approval
  • Oct. 18, 2023, 11:39 UTC
  • 31
  • 0 comments

FDA approve APREMILAST

Comment Full text

UCB INC

  • FDA Approval
  • Oct. 18, 2023, 11:39 UTC
  • 30
  • 0 comments

FDA approve LACOSAMIDE

Comment Full text

MYLAN GMBH

  • FDA Approval
  • Oct. 17, 2023, 15:33 UTC
  • 29
  • 0 comments

FDA approve PEGFILGRASTIM-JMDB

Comment Full text

EPIC PHARMA LLC

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 30
  • 0 comments

FDA approve AMPHETAMINE SULFATE

Comment Full text

SANDOZ

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 28
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

OSMOTICA PHARM US

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 31
  • 0 comments

FDA approve METHYLPHENIDATE HYDROCHLORIDE

Comment Full text

LANNETT CO INC

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 29
  • 0 comments

FDA approve AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Comment Full text
  • Previous
  • 651
  • 652
  • 653
  • 654
  • 655
  • Next

Search

News categories

  • Technical Exchange News(11980)
  • Event(5035)
  • SEC News(247694)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(148879)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin